DK175686B1 - Rekombinant DNA-sekvens for humant proapolipoprotein A-I, klonings- og ekspressionsvektor indeholdende sekvensen............. - Google Patents

Rekombinant DNA-sekvens for humant proapolipoprotein A-I, klonings- og ekspressionsvektor indeholdende sekvensen............. Download PDF

Info

Publication number
DK175686B1
DK175686B1 DK198802896A DK289688A DK175686B1 DK 175686 B1 DK175686 B1 DK 175686B1 DK 198802896 A DK198802896 A DK 198802896A DK 289688 A DK289688 A DK 289688A DK 175686 B1 DK175686 B1 DK 175686B1
Authority
DK
Denmark
Prior art keywords
human
dna sequence
sequence
proapo
expression vector
Prior art date
Application number
DK198802896A
Other languages
Danish (da)
English (en)
Other versions
DK289688A (da
DK289688D0 (da
Inventor
Jean Gobert
Ernst Wuelfert
Alex Bollen
Original Assignee
Ministere De La Region Wallonn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ministere De La Region Wallonn filed Critical Ministere De La Region Wallonn
Publication of DK289688D0 publication Critical patent/DK289688D0/da
Publication of DK289688A publication Critical patent/DK289688A/da
Application granted granted Critical
Publication of DK175686B1 publication Critical patent/DK175686B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775Apolipopeptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK198802896A 1987-05-28 1988-05-27 Rekombinant DNA-sekvens for humant proapolipoprotein A-I, klonings- og ekspressionsvektor indeholdende sekvensen............. DK175686B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8712540 1987-05-28
GB878712540A GB8712540D0 (en) 1987-05-28 1987-05-28 Expression of human proapolipoprotein a-i

Publications (3)

Publication Number Publication Date
DK289688D0 DK289688D0 (da) 1988-05-27
DK289688A DK289688A (da) 1988-11-29
DK175686B1 true DK175686B1 (da) 2005-01-17

Family

ID=10618034

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198802896A DK175686B1 (da) 1987-05-28 1988-05-27 Rekombinant DNA-sekvens for humant proapolipoprotein A-I, klonings- og ekspressionsvektor indeholdende sekvensen.............

Country Status (33)

Country Link
US (1) US5059528A (ja)
EP (1) EP0293357B1 (ja)
JP (1) JP2634193B2 (ja)
KR (1) KR970000808B1 (ja)
CN (1) CN1031892C (ja)
AT (1) ATE89006T1 (ja)
AU (1) AU615654B2 (ja)
CA (1) CA1323851C (ja)
CY (1) CY1809A (ja)
CZ (1) CZ283648B6 (ja)
DD (1) DD291093A5 (ja)
DE (1) DE3880739T2 (ja)
DK (1) DK175686B1 (ja)
EG (1) EG19101A (ja)
ES (1) ES2054878T3 (ja)
FI (1) FI100056B (ja)
GB (1) GB8712540D0 (ja)
HK (1) HK137794A (ja)
HU (1) HU204562B (ja)
IE (1) IE62422B1 (ja)
IL (1) IL86480A (ja)
LT (1) LT3600B (ja)
LV (1) LV5288A3 (ja)
NO (1) NO179253C (ja)
NZ (1) NZ224808A (ja)
PL (1) PL158064B1 (ja)
PT (1) PT87562B (ja)
RU (1) RU2009198C1 (ja)
SG (1) SG131594G (ja)
SK (1) SK279166B6 (ja)
SU (1) SU1834904A3 (ja)
UA (1) UA19765A (ja)
ZA (1) ZA883824B (ja)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU587989B2 (en) * 1984-10-16 1989-09-07 Mitsubishi Chemical Corporation DMA fragments, expression vectors, proteins, hosts, and process for production of the proteins
JP2606228B2 (ja) * 1987-09-18 1997-04-30 三菱化学株式会社 ヒトプロアポリポプロテインa−i様蛋白の産生法
EP0345155B1 (en) * 1988-05-31 1994-08-10 Mitsubishi Kasei Corporation Process for producing natural human apolipoprotein e-like proteins
US5846799A (en) * 1988-06-14 1998-12-08 La Region Wallone Human myeloperoxidase and its therapeutic application
US5460961A (en) * 1988-06-14 1995-10-24 La Region Wallonne Human myeloperoxidase and its therapeutic application
IT1229996B (it) * 1989-04-20 1991-09-20 Cesare Sirtori Espressione di apolipoproteina ai e apolipoproteina ai-milano in lievito e composizioni farmaceutiche che contengono dette apolipoproteine.
ATE158816T1 (de) * 1990-11-26 1997-10-15 Genetics Inst Expression von pace in wirtszellen und verfahren zu dessen verwendung
US5844097A (en) * 1990-11-30 1998-12-01 Monoclonetics International, Inc. Methods for the diagnosis of peripheral nerve damage
ATE132269T1 (de) * 1990-11-30 1996-01-15 Monoclonetics Int Verfahren zur diagnose chronischer niedriger rückenschmerzen und nackenschmerzen
SE9500778D0 (sv) * 1995-03-03 1995-03-03 Pharmacia Ab Process for producing a protein
US5994061A (en) * 1995-09-29 1999-11-30 Queen's University At Kingston DNA constructs and methods for screening for increased expression of human apo AI gene
SE9603068D0 (sv) 1996-08-23 1996-08-23 Pharmacia & Upjohn Ab Process for purifying a protein
SE9603304D0 (sv) 1996-09-11 1996-09-11 Pharmacia & Upjohn Ab Process for purifying a compound
SE9603303D0 (sv) 1996-09-11 1996-09-11 Pharmacia & Upjohn Ab Process for purifying a protein
KR100330355B1 (ko) * 1999-06-04 2002-04-01 장인순 회전유동발생 날개를 가진 덕트형 핵연료 집합체 지지격자
US20040047853A1 (en) * 2000-06-09 2004-03-11 Dahl Soren W Purified proenzyme of dipeptidyl peptidase i (pro-dppi)
AU2002232642B2 (en) * 2000-12-12 2007-02-01 Lexicon Pharmaceuticals, Inc. Novel human kinases and uses thereof
KR100560102B1 (ko) * 2004-06-25 2006-03-13 한국생명공학연구원 프로아포리포단백질 a-ⅰ 변이체와, 이를 포함하는고지혈증 또는 동맥경화증 예방 및 치료제
US7427662B2 (en) * 2005-02-01 2008-09-23 Baord Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Inhibition of angiogenesis and destruction of angiogenic vessels by apolipoprotein A-I and high density lipoprotein
US8206750B2 (en) 2005-03-24 2012-06-26 Cerenis Therapeutics Holding S.A. Charged lipoprotein complexes and their uses
CA2619943A1 (en) * 2005-08-26 2007-03-01 Cerenis Therapeutics Holding Sa Compositions and methods for producing apolipoprotein gene products in lactic acid bacteria
WO2008104890A2 (en) * 2007-02-28 2008-09-04 Cerenis Therapeutics Holding Sa Compositions and methods for producing apolipoprotein
MY188457A (en) * 2008-10-03 2021-12-10 Opko Curna Llc Treatment of apolipoprotein-a1 related diseases by inhibition of natural antisense transcript to apolipoprotein-a1
KR102344392B1 (ko) 2008-11-10 2021-12-28 알닐람 파마슈티칼스 인코포레이티드 치료제 운반용 신규 지질 및 조성물
AU2010208035B2 (en) 2009-01-29 2016-06-23 Arbutus Biopharma Corporation Improved lipid formulation for the delivery of nucleic acids
NZ594995A (en) 2009-03-12 2013-06-28 Alnylam Pharmaceuticals Inc LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF HUMAN KINESIN FAMILY MEMBER 11 (Eg5) AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) GENES
NZ621981A (en) 2009-05-05 2015-09-25 Tekmira Pharmaceuticals Corp Lipid compositions
US9155754B2 (en) 2009-05-06 2015-10-13 Curna, Inc. Treatment of ABCA1 gene related diseases by inhibition of a natural antisense transcript to ABCA1
EA201791744A3 (ru) 2009-06-10 2018-07-31 Арбутус Биофарма Корпорэйшн Улучшенная липидная композиция
WO2011020023A2 (en) 2009-08-14 2011-02-17 Alnylam Pharmaceuticals, Inc. Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
WO2011044545A2 (en) 2009-10-09 2011-04-14 Sigalov Alexander B Methods and compositions for targeted imaging
US9687550B2 (en) 2009-12-07 2017-06-27 Arbutus Biopharma Corporation Compositions for nucleic acid delivery
ES2749426T3 (es) 2009-12-18 2020-03-20 Univ British Columbia Métodos y composiciones para administración de ácidos nucleicos
WO2011139911A2 (en) 2010-04-29 2011-11-10 Isis Pharmaceuticals, Inc. Lipid formulated single stranded rna
WO2011143362A1 (en) 2010-05-11 2011-11-17 Esperion Therapeutics, Inc. Dimeric oxidation-resistant apolipoprotein a1 variants
DK2575764T3 (en) 2010-06-03 2017-08-07 Alnylam Pharmaceuticals Inc BIODEGRADABLE LIPIDS FOR THE ACTIVATION OF ACTIVE AGENTS
WO2012016184A2 (en) 2010-07-30 2012-02-02 Alnylam Pharmaceuticals, Inc. Methods and compositions for delivery of active agents
WO2012016188A2 (en) 2010-07-30 2012-02-02 Alnylam Pharmaceuticals, Inc. Methods and compositions for delivery of active agents
CN103370054A (zh) 2010-11-09 2013-10-23 阿尔尼拉姆医药品有限公司 用于抑制Eg5和VEGF基因的表达的脂质配制的组合物和方法
EP2663548B1 (en) 2011-01-11 2017-04-05 Alnylam Pharmaceuticals, Inc. Pegylated lipids and their use for drug delivery
CN103443123B (zh) 2011-02-07 2020-05-29 塞勒尼斯医疗控股公司 脂蛋白复合物及其制备和用途
EP2760477B1 (en) 2011-09-27 2018-08-08 Alnylam Pharmaceuticals, Inc. Di-aliphatic substituted pegylated lipids
US10894098B2 (en) 2012-04-09 2021-01-19 Signablok, Inc. Methods and compositions for targeted imaging
US9610324B2 (en) * 2012-07-11 2017-04-04 Esperion Therapeutics, Inc. Apolipoprotein mixtures
PT2992098T (pt) * 2013-05-01 2019-07-05 Ionis Pharmaceuticals Inc Composições e métodos para modular a expressão de hbv e ttr
EP2853259A1 (en) 2013-09-30 2015-04-01 Université Pierre et Marie Curie (Paris 6) Reconstituted high density lipoproteins composition and uses thereof
RU2016144908A (ru) 2014-05-02 2018-06-05 Серени Терапеутикс Холдинг Са Маркеры hdl-терапии
WO2018077159A1 (zh) * 2016-10-27 2018-05-03 中国科学院微生物研究所 氨基酸衰减子的改造方法及其在生产中的应用
EP3668549B1 (en) 2017-08-10 2024-05-15 Abionyx Pharma SA Apomers
WO2019030574A1 (en) 2017-08-10 2019-02-14 Cerenis Therapeutics Holding CARGOMÈRES
US11081113B2 (en) 2018-08-24 2021-08-03 Bright Marbles, Inc. Idea scoring for creativity tool selection
US11461863B2 (en) 2018-08-24 2022-10-04 Bright Marbles, Inc. Idea assessment and landscape mapping
US11164065B2 (en) 2018-08-24 2021-11-02 Bright Marbles, Inc. Ideation virtual assistant tools
US11189267B2 (en) 2018-08-24 2021-11-30 Bright Marbles, Inc. Intelligence-driven virtual assistant for automated idea documentation
CN115427064A (zh) 2020-04-16 2022-12-02 阿比奥尼克斯制药公司 使用基于脂质结合蛋白的复合物治疗急性病况的方法
US20240000948A1 (en) 2020-10-01 2024-01-04 Abionyx Pharma Sa Methods for treating eye diseases using lipid binding protein-based complexes
EP4322746A1 (en) 2021-04-15 2024-02-21 Abionyx Pharma SA Use of lipid binding protein-based complexes in organ preservation solutions
WO2023194798A1 (en) 2022-04-06 2023-10-12 Abionyx Pharma Sa Methods for treating leukocytosis, endothelial dysfunction and carditis using lipid binding protein-based complexes
WO2023194797A1 (en) 2022-04-06 2023-10-12 Abionyx Pharma Sa Methods for treating eye diseases using lipid binding protein-based complexes
WO2023237935A2 (en) 2022-06-10 2023-12-14 Abionyx Pharma Sa Methods for treating acute conditions using lipid binding protein-based complexes
WO2023237927A2 (en) 2022-06-10 2023-12-14 Abionyx Pharma Sa Methods for treating hyperinflammatory conditions using lipid binding protein -based complexes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU587989B2 (en) * 1984-10-16 1989-09-07 Mitsubishi Chemical Corporation DMA fragments, expression vectors, proteins, hosts, and process for production of the proteins
JPS6198998A (ja) 1984-10-18 1986-05-17 Matsushita Electric Ind Co Ltd 電動送風機
BE901119A (fr) 1984-11-23 1985-03-15 Wallone Region Procede de preparation de plasmides vecteurs capables de transformer un hote bacterien escherichia coli et d'y promouvoir et controler l'expression d'un adn heterologue.
DE3688418T2 (de) 1985-02-13 1993-08-26 Scios Nova Inc Menschlicher metallothionein ii-promotor in saeugetierexpressionssystemen.
GB8507833D0 (en) * 1985-03-26 1985-05-01 Biogen Nv Production of human somatomedin c
WO1987002062A1 (en) 1985-10-04 1987-04-09 Biotechnology Research Partners, Ltd. Recombinant apolipoproteins and methods
GB8625435D0 (en) * 1986-10-23 1986-11-26 Erba Farmitalia Human apolipoprotein ai
WO1988003175A1 (en) * 1986-10-29 1988-05-05 Biotechnology Research Partners, Ltd. Apoai-ciii-aiv, apoaii, apob, apoci, and ldl receptor polymorphisms for genetic fingerprinting and predictive of atherosclerosis

Also Published As

Publication number Publication date
SG131594G (en) 1995-01-13
JPS6416589A (en) 1989-01-20
CN88103118A (zh) 1988-12-14
US5059528A (en) 1991-10-22
ES2054878T3 (es) 1994-08-16
AU615654B2 (en) 1991-10-10
KR970000808B1 (en) 1997-01-20
HK137794A (en) 1994-12-16
UA19765A (uk) 1997-12-25
FI882456A0 (fi) 1988-05-25
DK289688A (da) 1988-11-29
EG19101A (en) 1994-09-29
SK363888A3 (en) 1998-07-08
PL158064B1 (pl) 1992-07-31
LT3600B (en) 1995-12-27
JP2634193B2 (ja) 1997-07-23
PL272698A1 (en) 1989-03-06
ATE89006T1 (de) 1993-05-15
NO882341L (no) 1988-11-29
DE3880739D1 (de) 1993-06-09
NZ224808A (en) 1990-01-29
IE881597L (en) 1988-11-28
NO179253C (no) 1996-09-04
CA1323851C (en) 1993-11-02
CN1031892C (zh) 1996-05-29
HU204562B (en) 1992-01-28
FI100056B (fi) 1997-09-15
DD291093A5 (de) 1991-06-20
LV5288A3 (lv) 1993-10-10
LTIP828A (en) 1995-02-27
CY1809A (en) 1995-10-20
EP0293357A1 (fr) 1988-11-30
IL86480A0 (en) 1988-11-15
SK279166B6 (sk) 1998-07-08
AU1672388A (en) 1988-12-01
DK289688D0 (da) 1988-05-27
GB8712540D0 (en) 1987-07-01
NO179253B (no) 1996-05-28
CZ363888A3 (cs) 1998-02-18
HUT47153A (en) 1989-01-30
PT87562A (pt) 1989-05-31
FI882456A (fi) 1988-11-29
KR880014110A (ko) 1988-12-22
IE62422B1 (en) 1995-02-08
ZA883824B (en) 1989-02-22
IL86480A (en) 1992-08-18
NO882341D0 (no) 1988-05-27
SU1834904A3 (ru) 1993-08-15
PT87562B (pt) 1992-09-30
CZ283648B6 (cs) 1998-05-13
RU2009198C1 (ru) 1994-03-15
DE3880739T2 (de) 1993-08-19
EP0293357B1 (fr) 1993-05-05

Similar Documents

Publication Publication Date Title
DK175686B1 (da) Rekombinant DNA-sekvens for humant proapolipoprotein A-I, klonings- og ekspressionsvektor indeholdende sekvensen.............
CA2070503C (en) A-c-b proinsulin, method of manufacturing and using same, and intermediates in insulin production
JP3014007B2 (ja) 組み換えヒト・インターロイキン―1インヒビターの生産
JP4341859B2 (ja) 酵母での異種タンパク質の発現の方法
EP0600866B1 (en) Compositions and methods for identifying biologically active molecules
FI106471B (fi) Menetelmä polypeptidien valmistamiseksi, polypeptidejä koodaava DNA-sekvenssi, ilmentämisvektori ja isäntäsolu
JP2004256541A (ja) インスリン様成長因子結合タンパク質とその組成物
JPH01501283A (ja) 新規な型のコロニー刺激因子―1
CZ264496A3 (en) Increase of polypeptide secretion
CN113683679B (zh) 一种重组i型人源化胶原蛋白c1l6t及其制备方法和用途
JPH08500606A (ja) グルカゴンアンタゴニスト及びグルカゴンアンタゴニストの検出法
FR2594846A1 (fr) Procede de preparation de la serum albumine humaine mature
JPH08503858A (ja) 生物活性ポリペプチド融合ダイマー
JP2001008697A (ja) E.コリでの非融合タンパク質の調製方法
CN113683681B (zh) 一种重组i型人源化胶原蛋白c1l3t及其制备方法和用途
JPH10262668A (ja) 血管形成誘導因子をコードするタンパク質コード配列を包含するdna配列
JP2002538757A (ja) 食欲制御活性を有するポリペプチド
KR0161656B1 (ko) 글루카곤의 생산방법
JPH05310791A (ja) プレクトレウリス・トリスチスの殺虫毒
JP2001258565A (ja) 遺伝子の発現を促進させ得る核酸
JPH06172394A (ja) 成長ホルモンレセプターの細胞質外c−ドメイン蛋白質
JPH07501934A (ja) Gpa神経栄養因子の製造
JPH03218398A (ja) ポリペプチド,dnaおよびその用途
JPH0795893A (ja) 新規なポリペプチド、その製造方法、そのポリペプチドをコードするdna、そのdnaからなるベクター、そのベクターで形質転換された宿主細胞、そのポリペプチドの抗体、およびそのポリペプチドまたは抗体を含有する薬学的組成物
JPH0691833B2 (ja) 利尿作用を有するポリペプチドの製造方法

Legal Events

Date Code Title Description
PUP Patent expired